Influence of Fluvastatin on Levels of von Willebrand Factor in Cardiac Transplant Recipients

Thromb Haemost 2000; 84(03): 514
DOI: 10.1055/s-0037-1614060

Letters to the Editor

Schattauer GmbH

Authors

A. D. Blann

¹From the Haemostasis, Thrombosis and Vascular Biology Unit, City Hospital, University Dept. of Medicine, Birmingham, UK

References
1 Ambrosi P, Aillaud MF, Habib G, Kreitmann B, Matras D, Luccioni R, Bouvenot G, Juhan-Vague I. Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipients. Thromb Haemost 2000; 83: 46-8.
2 Collins P, Wilkie M, Razak K, Abbott S, Harley S, Bax C, Zaidi M, Blake D, Cunningham J, Newland A. Cyclosporin and cremaphor modulate von Willebrand factor release from cultured endothelial cells. Transplantation 1993; 56: 1218-23.
3 Licciardello JTW, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42: 296-300.
4 Richard S, Seigneur M, Blann A, Adams R, Renard M, Puntous M, Boiron JM, Amiral J, Reiffers J, Boisseau M. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1996; 18: 955-9.